Title |
Overexpression of Forkhead Box M1 Transcription Factor (FOXM1) is a Potential Prognostic Marker and Enhances Chemoresistance for Docetaxel in Gastric Cancer
|
---|---|
Published in |
Annals of Surgical Oncology, October 2012
|
DOI | 10.1245/s10434-012-2680-0 |
Pubmed ID | |
Authors |
Kaoru Okada, Yoshiyuki Fujiwara, Tsuyoshi Takahashi, Yurika Nakamura, Shuji Takiguchi, Kiyokazu Nakajima, Hiroshi Miyata, Makoto Yamasaki, Yukinori Kurokawa, Masaki Mori, Yuichiro Doki |
Abstract |
Mammalian forkhead box transcription factor 1 (FoxM1) has been overexpressed and correlated with pathogenesis in a variety of human malignancies. We investigated the expression status and clinical significance of its overexpression in gastric adenocarcinoma. Furthermore, we demonstrated correlations between FoxM1 overexpression and drug resistance to chemotherapeutic agents in gastric cancer cells and gastric cancer patients treated with chemotherapy. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 3% |
Unknown | 29 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 6 | 20% |
Student > Bachelor | 3 | 10% |
Student > Master | 3 | 10% |
Student > Postgraduate | 2 | 7% |
Researcher | 2 | 7% |
Other | 3 | 10% |
Unknown | 11 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 30% |
Biochemistry, Genetics and Molecular Biology | 6 | 20% |
Agricultural and Biological Sciences | 4 | 13% |
Unknown | 11 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2022.
All research outputs
#6,652,922
of 23,500,709 outputs
Outputs from Annals of Surgical Oncology
#2,246
of 6,651 outputs
Outputs of similar age
#47,558
of 173,791 outputs
Outputs of similar age from Annals of Surgical Oncology
#16
of 51 outputs
Altmetric has tracked 23,500,709 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 6,651 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,791 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.